These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12693739)

  • 1. Genetic editing of dysfunctional myocardium.
    Hajjar RJ; Huq F; Matsui T; Rosenzweig A
    Med Clin North Am; 2003 Mar; 87(2):553-67. PubMed ID: 12693739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for gene therapy for heart failure.
    Hajjar RJ; del Monte F; Matsui T; Rosenzweig A
    Circ Res; 2000 Mar; 86(6):616-21. PubMed ID: 10746995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for heart failure.
    Thompson RB; Rungwerth K; Koch WJ
    Ann Med; 2004; 36 Suppl 1():106-15. PubMed ID: 15176432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for the treatment of heart failure--calcium signaling.
    Bernecker OY; del Monte F; Hajjar RJ
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):268-76. PubMed ID: 12973704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus gene transfer of SERCA in heart failure. A promising therapeutic approach ?
    Baartscheer A
    Cardiovasc Res; 2001 Feb; 49(2):249-52. PubMed ID: 11164834
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.
    Pleger ST; Boucher M; Most P; Koch WJ
    J Card Fail; 2007 Jun; 13(5):401-14. PubMed ID: 17602988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy in heart failure.
    Vinge LE; Raake PW; Koch WJ
    Circ Res; 2008 Jun; 102(12):1458-70. PubMed ID: 18566312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-specific selection of molecular targets for heart failure gene therapy.
    Katz MG; Fargnoli AS; Tomasulo CE; Pritchette LA; Bridges CR
    J Gene Med; 2011 Oct; 13(10):573-86. PubMed ID: 21954055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRK2 as a novel gene therapy target in heart failure.
    Rengo G; Lymperopoulos A; Leosco D; Koch WJ
    J Mol Cell Cardiol; 2011 May; 50(5):785-92. PubMed ID: 20800067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted gene therapy for the treatment of cardiac dysfunction.
    Askari AT; Penn MS
    Semin Thorac Cardiovasc Surg; 2002 Apr; 14(2):167-77. PubMed ID: 11988956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis in heart failure. -The role of the β-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes-.
    Fujita T; Ishikawa Y
    Circ J; 2011; 75(8):1811-8. PubMed ID: 21747195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent findings into the potential of gene therapy to reverse heart failure.
    Pleger ST; Most P; Koch WJ
    Expert Opin Biol Ther; 2007 Dec; 7(12):1781-4. PubMed ID: 18034643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy in Heart Failure.
    Fargnoli AS; Katz MG; Bridges CR; Hajjar RJ
    Handb Exp Pharmacol; 2017; 243():395-421. PubMed ID: 27796512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components.
    Maurice JP; Koch WJ
    Coron Artery Dis; 1999 Sep; 10(6):401-5. PubMed ID: 10474791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic manipulation of beta-adrenergic signalling in heart failure.
    Davidson MJ; Koch WJ
    Acta Physiol Scand; 2001 Sep; 173(1):145-50. PubMed ID: 11678737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.
    Hajjar RJ; Zsebo K; Deckelbaum L; Thompson C; Rudy J; Yaroshinsky A; Ly H; Kawase Y; Wagner K; Borow K; Jaski B; London B; Greenberg B; Pauly DF; Patten R; Starling R; Mancini D; Jessup M
    J Card Fail; 2008 Jun; 14(5):355-67. PubMed ID: 18514926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy targets in heart failure: the path to translation.
    Raake PW; Tscheschner H; Reinkober J; Ritterhoff J; Katus HA; Koch WJ; Most P
    Clin Pharmacol Ther; 2011 Oct; 90(4):542-53. PubMed ID: 21866097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery.
    Maurice JP; Hata JA; Shah AS; White DC; McDonald PH; Dolber PC; Wilson KH; Lefkowitz RJ; Glower DD; Koch WJ
    J Clin Invest; 1999 Jul; 104(1):21-9. PubMed ID: 10393695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for heart failure.
    Greenberg B
    Trends Cardiovasc Med; 2017 Apr; 27(3):216-222. PubMed ID: 28063800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.
    Hata JA; Williams ML; Koch WJ
    J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.